101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic
F. Gomes, N. Gilding, V. Tan, K. Christoforou, J. Rule, A. Aziez, Adam Januszewski, A. Minchom
{"title":"101 Real-world analysis of the impact of pemetrexed in first-line maintenance (1LM) with immunotherapy (IO) for non-squamous (NSQ) advanced/metastatic non-small cell lung cancer (a/mNSCLC) lacking targetable mutations, prior to and during the COVID-19 pandemic","authors":"F. Gomes, N. Gilding, V. Tan, K. Christoforou, J. Rule, A. Aziez, Adam Januszewski, A. Minchom","doi":"10.1016/j.lungcan.2024.107662","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":507097,"journal":{"name":"Lung cancer","volume":"11 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.lungcan.2024.107662","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
